Peptidream Inc. is a biopharmaceutical company based in Kanagawa, Japan, specializing in the discovery and development of peptide-based therapeutics. The company leverages its proprietary Peptide Discovery Platform Technology (PDPT) to create novel peptides that can be utilized in various therapeutic areas, including oncology and metabolic diseases. Peptidream's innovative approach focuses on enhancing the efficacy and specificity of peptide drugs, positioning it as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#139 in Kanagawa

#3,934 in Japan

#48,129 in the World

Kanagawa, Japan

Peptidream Inc.

Forward Citations = 16

37 inventors:

Patrick Reid (7 out of 10 patents)

Keiichi Masuya (4 out of 4 patents)

Takashi Kawakami (3 out of 54 patents)

4. Hiroshi Murakami (3 out of 29 patents)

5. Masaki Ohuchi (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peptidream Inc.. Retrieved from https://idiyas.com/company/peptidream

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]